ConductScience.org, home

Paper6404446

Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia.

Ekue JM and 2 others. Br Med J (Clin Res Ed), 1983. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia. Papers, record 6404446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6404446

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia.
PubMed
Journal
Br Med J (Clin Res Ed)
PubMed
Year
1983
PubMed
Publication types
Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2019-05-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ekue JMJ M
2Ulrich AMA M
3Njelesani EKE K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChloroquineMajor topic
MalariaMajor topic
Plasmodium falciparumMajor topic
Adult
Drug Resistance, Microbial
Female
Humans
Zambia

Source PubMed

Download CSV of topics

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11105787Mefloquine (WR 142,490) in the treatment of human malaria.Science1975https://conductscience.org/library/papers/1105787PubMed
291887Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist.Lancet1979https://conductscience.org/library/papers/91887PubMed
3382468Chloroquine-resistant Plasmodium falciparum malaria in Kenya.Trans R Soc Trop Med Hyg1979https://conductscience.org/library/papers/382468PubMed

Download CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
31796087En-route to the 'elimination' of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal.Malar J2019https://conductscience.org/library/papers/31796087PubMed
31341510Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective.Comput Math Methods Med2019https://conductscience.org/library/papers/31341510PubMed
23298401Operational scale entomological intervention for malaria control: strategies, achievements and challenges in Zambia.Malar J2013https://conductscience.org/library/papers/23298401PubMed
21915314Insecticide resistance and the future of malaria control in Zambia.PLoS One2011https://conductscience.org/library/papers/21915314PubMed
21352609Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.Malar J2011https://conductscience.org/library/papers/21352609PubMed
20162091Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria.Afr J Tradit Complement Altern Med2006https://conductscience.org/library/papers/20162091PubMed
14726463History, dynamics, and public health importance of malaria parasite resistance.Clin Microbiol Rev2004https://conductscience.org/library/papers/14726463PubMed
6397277The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.Bull World Health Organ1984https://conductscience.org/library/papers/6397277PubMed
3893778A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.Bull World Health Organ1985https://conductscience.org/library/papers/3893778PubMed
3893777[Drug resistance of Plasmodium falciparum in Burundi].Bull World Health Organ1985https://conductscience.org/library/papers/3893777PubMed
3311440A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.Bull World Health Organ1987https://conductscience.org/library/papers/3311440PubMed
3311439Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.Bull World Health Organ1987https://conductscience.org/library/papers/3311439PubMed
3081151Chloroquine resistant Plasmodium falciparum malaria in Zimbabwe.Br Med J (Clin Res Ed)1986https://conductscience.org/library/papers/3081151PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6404446

GET https://conductscience.org/api/papers/v1/6404446/authors